Related Experiment Video
Updated: Oct 12, 2025

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
Published on: May 17, 2024
Brain Cancers in Genetic Syndromes
Edina Komlodi-Pasztor1, Jaishri O Blakeley2
1Department of Neurology, Division of Neuro-Oncology, Johns Hopkins University School of Medicine, 600 North Wolfe Street, Meyer 100, MD, 21287, Baltimore, USA.
Genetic conditions like Lynch syndrome, neurofibromatosis 1, and Li-Fraumeni syndrome are rare causes of primary brain tumors. Understanding these genetic disorders improves treatment and surveillance for patients with central nervous system cancers.
Area of Science:
- Neuro-oncology
- Genetics
- Molecular Diagnostics
Background:
- Genetic conditions are rare causes of primary central nervous system tumors.
- The pathophysiology of these genetic disorders significantly impacts treatment and surveillance strategies.
- Awareness of genetic predispositions is crucial for accurate diagnosis and patient management.
Purpose of the Study:
- To review common genetic conditions associated with brain cancers.
- To highlight recent therapeutic advances for specific genetic syndromes.
- To emphasize the importance of diagnosing genetic conditions for improved patient outcomes.
Main Methods:
- Literature review of genetic conditions linked to primary brain tumors.
- Analysis of recent therapeutic approaches for Lynch syndrome, neurofibromatosis 1, and Li-Fraumeni syndrome.
- Discussion of the role of molecular diagnostics in identifying genetic predispositions.
Main Results:
- Identified frequently occurring genetic conditions associated with brain cancers.
- Highlighted novel therapeutic strategies for Lynch syndrome (mismatch repair system disorders), neurofibromatosis 1, and Li-Fraumeni syndrome.
- Emphasized the increasing role of next-generation sequencing in detecting genetic conditions.
Conclusions:
- Accurate diagnosis of underlying genetic conditions is vital for effective patient management.
- Advances in molecular diagnostics aid in identifying patients requiring germline genetic testing.
- Understanding genetic variants influencing brain tumors can lead to personalized and improved therapeutic interventions.
More Related Videos
10:58Transposon Mediated Integration of Plasmid DNA into the Subventricular Zone of Neonatal Mice to Generate Novel Models of Glioblastoma
Published on: February 22, 2015
08:22A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations
Published on: December 1, 2017
Related Concept Videos
Cancer Prevention
Some...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Genomic Imprinting and Inheritance
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
Cancers Originate from Somatic Mutations in a Single Cell
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...